Jeffrey Nau

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Brandon Fenn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Nau:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oyster Point Pharma, Inc. President and CEO, Director Common Stock 0 $11.20 03 Jan 2023 By Spouse
Oyster Point Pharma, Inc. President and CEO, Director Common Stock 0 $11.20 03 Jan 2023 Direct
Oyster Point Pharma, Inc. President and CEO, Director Performance Stock Units 0 03 Jan 2023 Direct
Oyster Point Pharma, Inc. President and CEO, Director Stock Option (Right to Buy) 0 03 Jan 2023 Direct

Insider Reports Filed by Jeffrey Nau

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122060117-nau-jeffrey-2022-12-01-restatement Oyster Point Pharma, Inc. 01 Dec 2022 1 -$100,106 4/A President and CEO, Director 06 Dec 2022, 18:05
/report/000120919122041675-nau-jeffrey-2022-07-06 Oyster Point Pharma, Inc. 06 Jul 2022 1 $0 4 President and CEO, Director 08 Jul 2022, 16:54
/report/000120919123001084-nau-jeffrey-2022-01-29 Oyster Point Pharma, Inc. 29 Jan 2022 11 -$30,502 4 President and CEO, Director 04 Jan 2023, 16:06
/report/000120919122002979-nau-jeffrey-2022-01-09 Oyster Point Pharma, Inc. 09 Jan 2022 2 $0 4 President and CEO, Director 11 Jan 2022, 18:46
/report/000120919121061371-nau-jeffrey-2021-10-21 Oyster Point Pharma, Inc. 21 Oct 2021 2 +$51,000 4 President and CEO, Director 22 Oct 2021, 16:41
/report/000120919121054298-nau-jeffrey-2021-09-01 Oyster Point Pharma, Inc. 01 Sep 2021 2 +$10,200 4 President and CEO, Director 01 Sep 2021, 18:00